Longevity News

A novel design of chimeric multi-epitope vaccine based on moonlighting proteins of Anaplasma marginale is identified by protective antibodies

Source: Nature - Biotechnology • Published: 29 Aug 2026, 00:00

A novel design of chimeric multi-epitope vaccine based on moonlighting proteins of Anaplasma marginale is identified by protective antibodies

How a computationally designed chimeric multi-epitope vaccine against a cattle tick‑borne pathogen was created and validated by antibody recognition.

Key Takeaways
  • It is citable and carries a permanent DOI
  • This version is subject to further edits and will be replaced automatically by the final Version of Record
  • Bovine anaplasmosis is a disease caused by Anaplasma marginale that affects cattle
Read Original Source

Continue exploring

Related longevity signals

Nature - BiotechnologyProteome-wide immunoinformatics and molecular dynamics reveal a multi-epitope vaccine construct targeting Nipah virus glycoprotein GA computational research article describing design and in silico evaluation of a multi-epitope vaccine targeting a viral surface glycoprotein, inviting readers curious about bioinformatics-driven vaccine development.Nature - BiotechnologyMolecular mechanism analysis of natural leaf abscission in sugarcane based on multi-omics and mining of key genes in ABA pathwayReports multi-omics analysis linking carotenoid metabolism and ABA signaling to natural leaf abscission in sugarcane, highlighting candidate genetic targets.Nature - BiotechnologyDesign and characterization of an injectable biohybrid hydrogel based on chitosan/silk fibroin/hyaluronic acid and containing bioactive glass for bone tissue engineeringCovers development and lab characterization of an injectable biohybrid hydrogel combining natural polymers and bioactive glass for bone repair applications.Nature - MainRewiring the ribosome to translate proteins encoded in its own RNA - NatureReport on engineering ribosomes that carry and translate appended protein-coding sequences, creating self-encoding ribosome constructs for orthogonal protein synthesis.